Prescription drug · BLA
Merilog (Insulin aspart-szjj) NDC 0024-5928
Insulin aspart 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous · Sanofi-Aventis U.S. LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0024-5928-05 | 0002459280500024592805 | 5 SYRINGE in 1 BOX (0024-5928-05) / 3 mL in 1 SYRINGE (0024-5928-00)Marketed from Feb 14, 2025 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Merilog
- Generic name (nonproprietary)
- insulin aspart-szjj
- Active ingredients
- Insulin aspart — 100 [iU]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- Sanofi-Aventis U.S. LLCNDC labeler code 0024
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761325
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 0024-5928_cfcdd91c-ec57-416b-959e-0fd59030bcbbSPL ID cfcdd91c-ec57-416b-959e-0fd59030bcbbSPL set ID eee07a52-1102-4d48-9782-26061db175adRxCUI 2705733, 2705739, 2705741, 2705745UNII D933668QVX
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400024592805followed by a unit qualifier and the quantityPackage 00024-5928-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. MERILOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 0024-5928
- What is NDC 0024-5928?
- 0024-5928 is the product NDC for Merilog (insulin aspart-szjj), Insulin aspart 100 [iU]/mL injection, solution, listed with the FDA by Sanofi-Aventis U.S. LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Merilog (Insulin aspart-szjj).
- What is the active ingredient?
- Insulin aspart.
- Who is the labeler?
- Sanofi-Aventis U.S. LLC, NDC labeler code 0024. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Merilog?
- 1 other product NDC are listed under this name. See all Merilog NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Merilog products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Meriloginsulin aspart-szjj | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5927 | 00024-5927-00 |
Other NDCs under BLA 761325
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meriloginsulin aspart-szjj | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5927 |